Plain-English translation of NCT06998628 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a medication called can help reduce inflammation and joint damage in people with rheumatoid arthritis. Half of the participants will continue their regular arthritis treatment, while the other half will add to their regular treatment for three months. Researchers want to see if the medication helps decrease swelling, pain, and stiffness better than traditional treatment alone.
Rheumatoid arthritis causes long-term joint inflammation that can gradually damage joints and make everyday activities difficult. Doctors are exploring whether this medication, which has anti-inflammatory properties, might give patients better relief when combined with their existing treatments.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either continue your current arthritis medications alone, or to add (a pill taken twice daily at 400 mg) to your regular treatment. The entire study lasts three months, during which you will likely have clinic visits to check how you're doing and measure improvements in your joint symptoms like swelling and stiffness. Your doctor will monitor you to make sure the treatment is working and safe for you.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt